Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings

Partnershipproprietary peptide platformPositive

AI Analysis

Summary

Vector Science and Therapeutics Corp. signed an amended 10-year manufacturing and testing agreement with LyoGenesis Holdings to secure U.S.-based cGMP manufacturing capacity for its proprietary peptide platform, with quality testing performed by affiliate Verlytix.

Importance:5/10

Sentiment:

0.40

manufacturing agreementcGMP capacitylong-term partnershippeptide platform

Related Companies

$PAIN

Read the original article

Published by PR Newswire Biotech on August 17, 2026 11:45 AM

Read Original